Jeremy Shefner, MD
Enriched profileProfessor and Chair of Neurology · Barrow Neurological Institute
Jeremy Shefner is Professor and Chair of Neurology at Barrow Neurological Institute. OpenAlex indexes 322 publications with 16,207 citations (h-index 71); ClinicalTrials.gov lists 12 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Jeremy Shefner, MD, is Professor and Chair of Neurology at Barrow Neurological Institute. The public record shows 322 publications with 16,207 citations (h-index 71), centered on Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Parkinson's Disease Mechanisms and Treatments. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 22 companies, 1 NIH-funded awards (2018–2022).
- Most recent indexed publication: 2026 · Muscle & nerve
- Top research focus: Amyotrophic Lateral Sclerosis Research
- 12 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 13 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 188.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Contributed to FDA draft guidance for ALS drug development (issued February 2018)
incorporating recommendations from clinical investigators, industry, and advocates
2018provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologytoday.aan.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- Ciprofloxacin/Celecoxib Combination in Patients With ALS
Sponsor: NeuroSense Therapeutics Ltd.
- ALS Testing Through Home-based Outcome Measures
Sponsor: Jeremy Shefner
- Study of Electrical Impedance Myography (EIM) in ALS
Sponsor: Skulpt, Inc.
Industry payments
Updated 16 Oct 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year202510 payments$16,084openpaymentsdata.cms.gov ↗
- ARGENX US, INC.Program year20252 payments
- BioMarin Pharmaceutical Inc.Program year20251 payment
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Benzothiazole100%Riluzole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
1 NIH research award on record, funded 2018–2022 per NIH RePORTER. The latest:
- Access for All in ALS (ALL ALS) East Clinical Coordinating Center
Massachusetts General Hospital
FY2026$22,407,270OT2NS136938 - Access for All in ALS (ALL ALS) East Clinical Coordinating Center
Massachusetts General Hospital
FY2025$14,357,590OT2NS136938 - Access for All in ALS (ALL ALS) East Clinical Coordinating Center
Massachusetts General Hospital
FY2024$15,032,251OT2NS136938
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The Use of Durable Medical Equipment in COURAGE-ALS, a Phase 3, Multicentre, Randomized Clinical Trial for ALS.
Muscle & nerve
Clinical Trial2026 - Participant, site personnel and sponsor perspectives on decentralized trial features in COURAGE-ALS: a randomized clinical trial.
Amyotrophic lateral sclerosis & frontotemporal degeneration
Clinical Trial2025 - Failures to Replicate: What Recent Negative Phase 3 Trials Have Taught Us about Amyotrophic Lateral Sclerosis Clinical Research.
Annals of neurology
Editorial2024 - Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial.
Amyotrophic lateral sclerosis & frontotemporal degeneration
Clinical Trial2024
Most-cited works
by citation count (OpenAlex)- 01Electrodiagnostic criteria for diagnosis of ALS1,180 citations2008
- 02A proposal for new diagnostic criteria for ALS581 citations2020
- 04A revision of the El Escorial criteria - 2015479 citations2015
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jeremy-shefner-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/jeremy-shefner-980527122
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Jeremy-Shefner-2
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗ - X / Twitter
x.com/jeremyshefner
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/barrowneuro/p/By3KswFn1pR
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →phoenixmed.arizona.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →phoenixmed.arizona.edu ↗
- Board Certified
Neurology - General Certificate, American Board of Psychiatry and Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →phoenixmed.arizona.edu ↗ - Board Certified
Clinical Neurophysiology - Subspecialty Certificate, American Board of Psychiatry and Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →phoenixmed.arizona.edu ↗ - Board Certified
Neuromuscular Medicine - Subspecialty Certificate, American Board of Psychiatry and Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →phoenixmed.arizona.edu ↗
Editorial & leadership roles
journal and society appointments- Founder and Co-Chair
Northeast ALS Clinical Trials Consortium (NEALS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →barrowneuro.org ↗ - Member
American Academy of Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →barrowneuro.org ↗ - Member
American Association of Electrodiagnostic Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →barrowneuro.org ↗ - Member
American Neurological Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →barrowneuro.org ↗ - Neuromuscular Section Editor
UpToDate; Editorial Board, Neurotherapeutics and Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration journal
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sciencedirect.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →barrowneuro.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →barrowneuro.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →barrowneuro.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗
- Professor
Clinical Scholar in Neurology, University of Arizona College of Medicine – Phoenix
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →phoenixmed.arizona.edu ↗ - Chief Medical Officer for Clinical Research
Barrow Neurological Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗ - Scientific Advisory Board member
NewcelX (ALS/AstroRx cell therapy program)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗ - Kemper and Ethel Marley Professor and Chair of Neurology and Senior Vice President
Barrow Neurological Institute; Executive Chair of Neurology, University of Arizona Phoenix
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neuronext.org ↗
Media & interviews
press, podcasts and appearances- Grand Rounds presenter
"Pridopidine in ALS: Results from the Healey Platform Trial", Rethinking Clinical Trials
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rethinkingclinicaltrials.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →barrowneuro.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Marwan Sabbagh, MD
Barrow Neurological Institute
Michael Lawton, MD
Barrow Neurological Institute
Yonas Geda, MD, MSc
Barrow Neurological Institute
Nader Sanai, MD
Barrow Neurological Institute
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida